DVA DaVita Inc

  1. Stocks
  2. Healthcare
  3. NYSE: DVA

Price (delayed)

$236.12

Market cap

$15.16B

P/E Ratio

21.6

Dividend/share

N/A

EPS

$10.93

Enterprise value

$27.65B

?
Relative Growth: Rel. Growth: 68
Relative Strength: Rel. Strength: 95
Relative Valuation: Rel. Valuation: 67
Relative Profitability: Rel. Profitability: 39

Inc. DaVita is a healthcare provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader ...

Highlights
DVA's quick ratio is up by 13% year-on-year and by 11% since the previous quarter
The EPS has grown by 9% from the previous quarter and by 6% YoY
DVA's net income is down by 9% year-on-year but it is up by 4.6% since the previous quarter
DVA's equity has dropped by 183% year-on-year and by 16% since the previous quarter
DVA's price to earnings (P/E) is 68% higher than its last 4 quarters average of 13.1 and 60% higher than its 5-year quarterly average of 13.7
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.davita.com
Peers: THC MD UHS LH

Key stats

What are the main financial stats of DVA

DVA stock price

How has the DaVita stock price performed over time
Intraday
-1.65%
1 week
-0.08%
1 month
0.52%
1 year
70.51%
YTD
107.83%
QTD
6.13%

Financial performance

How have DaVita's revenue and profit performed over time
Revenue
$13.84B
Gross profit
$4.49B
Operating income
$2.05B
Net income
$781.42M
Gross margin
32.4%
Net margin
5.6%
The net margin has contracted by 15% YoY
DVA's net income is down by 9% year-on-year but it is up by 4.6% since the previous quarter
The gross profit has increased by 7% YoY and by 2% from the previous quarter
DaVita's revenue has increased by 7% YoY

Price vs fundamentals

How does DVA's price correlate with its fundamentals

Growth

What is DaVita's growth rate over time

Valuation

What is DaVita stock price valuation
DVA P/E details
P/E
21.6
P/B
N/A
P/S
1.15
EV/EBIT
16.49
EV/EBITDA
11.55
EV/Sales
2
DVA's price to earnings (P/E) is 68% higher than its last 4 quarters average of 13.1 and 60% higher than its 5-year quarterly average of 13.7
The EPS has grown by 9% from the previous quarter and by 6% YoY
DVA's equity has dropped by 183% year-on-year and by 16% since the previous quarter
The price to sales (P/S) is 67% more than the last 4 quarters average of 0.7 and 46% more than the 5-year quarterly average of 0.8
DaVita's revenue has increased by 7% YoY

Efficiency

How efficient is DaVita business performance
The ROA has decreased by 10% YoY but it has increased by 4.7% from the previous quarter
The ROS has contracted by 4% YoY
DaVita's return on invested capital has increased by 2.3% QoQ

Dividends

What is DVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DVA.

Financial health

How did DaVita financials performed over time
DVA's total assets is 6% greater than its total liabilities
The current ratio rose by 14% YoY and by 10% QoQ
DVA's quick ratio is up by 13% year-on-year and by 11% since the previous quarter
DVA's equity has dropped by 183% year-on-year and by 16% since the previous quarter
DaVita's debt to equity has soared by 62% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.